Aldeyra Therapeutics, Inc.
About
1.75USD+0.00 +0.00%
Closed • Updated at 06:51 GMT+00:00Market Cap$105.56M
Volume579.9K
Beta2.88
RSI50.59
Aldeyra Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Feb 18 2026
Aldeyra Therapeutics to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Dec 16 2025
Aldeyra Therapeutics Announces PDUFA Extension of the New Drug Application of Reproxalap for the Treatment of Dry Eye Disease
Nov 13 2025
Aldeyra Therapeutics Announces Expansion of RASP Platform to Include Central Nervous System Diseases and Provides Updates on Reproxalap at Research & Development Webcast
Nov 11 2025
Aldeyra Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
Nov 6 2025
Aldeyra Therapeutics to Host Research & Development Update Webcast Event Scheduled for Thursday, November 13 at 8:00 a.m. ET
Community Chat
Ask AI
Try asking